Back to Search
JENNIFER PLUMB, MD, MPH
MD, MPH
Pediatrics Physician
NPI: 1992819296IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
53342911205(UT)
Education
UNIVERSITY OF UTAH SCHOOL OF MEDICINE
Class of 2000
Research & Publications (20)
Increased T-regulatory cells within lymphocyte follicles in moderate COPD.
PMID 19196820·Eur Respir J·2009
8-other
How guidance on the use of interventional procedures is produced in different countries: an international survey.
PMID 19366495·Int J Technol Assess Health Care·2009
8-other
The social and behavioral foundations of men's health--a public health perspective.
PMID 16516677·Prim Care·2006
6-review
Dysfunctional cystic fibrosis transmembrane conductance regulator inhibits phagocytosis of apoptotic cells with proinflammatory consequences.
PMID 19633071·Am J Physiol Lung Cell Mol Physiol·2009
7-preclinical
Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery.
PMID 19243718·Clin Ther·2009
4-observational
How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? An analysis of the UK General Practice Research Database.
PMID 19277415·Thromb Haemost·2009
4-observational
Dynamic telomerase gene suppression via network effects of GSK3 inhibition.
PMID 19649288·PLoS One·2009
4-observational
Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control.
PMID 19062079·Thromb Res·2009
8-other
Circadian timing in the lung; a specific role for bronchiolar epithelial cells.
PMID 18787022·Endocrinology·2009
7-preclinical
Cost-effectiveness of warfarin: trial versus "real-world" stroke prevention in atrial fibrillation.
PMID 19464418·Am Heart J·2009
8-other
Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504).
PMID 19004925·J Pharmacol Exp Ther·2009
8-other
Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis.
PMID 19132192·Thromb Haemost·2009
1-meta
Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo.
PMID 19259094·Br J Cancer·2009
4-observational
A phase 1 pharmacokinetic and pharmacodynamic study of the histone deacetylase inhibitor belinostat in patients with advanced solid tumors.
PMID 18245542·Clin Cancer Res·2008
3-trial
Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?
PMID 18573187·J Thromb Haemost·2008
8-other
Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta-analysis of the literature.
PMID 18402715·Curr Med Res Opin·2008
1-meta
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 100 N MEDICAL DR
SALT LAKE CITY, UT 84113 - Phone
- (801) 587-7450
Quick Facts
- NPI
- 1992819296
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile